Literature DB >> 20956525

Role of interferon {alpha} (IFN{alpha})-inducible Schlafen-5 in regulation of anchorage-independent growth and invasion of malignant melanoma cells.

Efstratios Katsoulidis1, Evangelos Mavrommatis, Jennifer Woodard, Mario A Shields, Antonella Sassano, Nathalie Carayol, Konrad T Sawicki, Hidayatullah G Munshi, Leonidas C Platanias.   

Abstract

IFNα exerts potent inhibitory activities against malignant melanoma cells in vitro and in vivo, but the mechanisms by which it generates its antitumor effects remain unknown. We examined the effects of interferon α (IFNα) on the expression of human members of the Schlafen (SLFN) family of genes, a group of cell cycle regulators that mediate growth-inhibitory responses. Using quantitative RT-real time PCR, we found detectable basal expression of all the different human SLFN genes examined (SLFN5, SLFN11, SLFN12, SLFN13, and SLFN14), in malignant melanoma cells and primary normal human melanocytes, but SLFN5 basal expression was suppressed in all analyzed melanoma cell lines. Treatment of melanoma cells with IFNα resulted in induction of expression of SLFN5 in malignant cells, suggesting a potential involvement of this gene in the antitumor effects of IFNα. Importantly, stable knockdown of SLFN5 in malignant melanoma cells resulted in increased anchorage-independent growth, as evidenced by enhanced colony formation in soft agar assays. Moreover, SLFN5 knockdown also resulted in increased invasion in three-dimensional collagen, suggesting a dual role for SLFN5 in the regulation of invasion and anchorage-independent growth of melanoma cells. Altogether, our findings suggest an important role for the SLFN family of proteins in the generation of the anti-melanoma effects of IFNα and for the first time directly implicate a member of the human SLFN family in the regulation of cell invasion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20956525      PMCID: PMC3001013          DOI: 10.1074/jbc.M110.151076

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  Regulatory effects of mammalian target of rapamycin-activated pathways in type I and II interferon signaling.

Authors:  Surinder Kaur; Lakhvir Lal; Antonella Sassano; Beata Majchrzak-Kita; Maya Srikanth; Darren P Baker; Emmanuel Petroulakis; Nissim Hay; Nahum Sonenberg; Eleanor N Fish; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2006-11-17       Impact factor: 5.157

Review 2.  Melanoma.

Authors:  Arlo J Miller; Martin C Mihm
Journal:  N Engl J Med       Date:  2006-07-06       Impact factor: 91.245

Review 3.  Complex modulation of cell type-specific signaling in response to type I interferons.

Authors:  Anette H H van Boxel-Dezaire; M R Sandhya Rani; George R Stark
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

Review 4.  The p38 mitogen-activated protein kinase pathway in interferon signal transduction.

Authors:  Efstratios Katsoulidis; Yongzhong Li; Heather Mears; Leonidas C Platanias
Journal:  J Interferon Cytokine Res       Date:  2005-12       Impact factor: 2.607

5.  Role of the p38 mitogen-activated protein kinase pathway in the generation of arsenic trioxide-dependent cellular responses.

Authors:  Nick Giafis; Efstratios Katsoulidis; Antonella Sassano; Martin S Tallman; Linda S Higgins; Angel R Nebreda; Roger J Davis; Leonidas C Platanias
Journal:  Cancer Res       Date:  2006-07-01       Impact factor: 12.701

6.  Histone deacetylase inhibitors suppress IFNalpha-induced up-regulation of promyelocytic leukemia protein.

Authors:  Jana Vlasáková; Zora Nováková; Lenka Rossmeislová; Michal Kahle; Pavel Hozák; Zdenek Hodny
Journal:  Blood       Date:  2006-10-24       Impact factor: 22.113

7.  Novel transcriptional regulation of the schlafen-2 gene in macrophages in response to TLR-triggered stimulation.

Authors:  Wern-Joo Sohn; Dongbum Kim; Keun-Wook Lee; Min-Soo Kim; Sanghoon Kwon; Younghee Lee; Doo-Sik Kim; Hyung-Joo Kwon
Journal:  Mol Immunol       Date:  2007-04-16       Impact factor: 4.407

8.  Activation of the p38 mitogen-activated protein kinase by type I interferons.

Authors:  S Uddin; B Majchrzak; J Woodson; P Arunkumar; Y Alsayed; R Pine; P R Young; E N Fish; L C Platanias
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

9.  Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells.

Authors:  Gregory B Lesinski; John Trefry; Melanie Brasdovich; Sri Vidya Kondadasula; Korkor Sackey; Jason M Zimmerer; Abhik Ray Chaudhury; Lianbo Yu; Xiaoli Zhang; Tim R Crespin; Michael J Walker; William E Carson
Journal:  Clin Cancer Res       Date:  2007-09-01       Impact factor: 12.531

10.  Activation of the mitogen- and stress-activated kinase 1 by arsenic trioxide.

Authors:  Padma Kannan-Thulasiraman; Efstratios Katsoulidis; Martin S Tallman; J Simon C Arthur; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2006-06-08       Impact factor: 5.157

View more
  40 in total

1.  Schlafen 12 expression modulates prostate cancer cell differentiation.

Authors:  Pavlo L Kovalenko; Marc D Basson
Journal:  J Surg Res       Date:  2014-03-27       Impact factor: 2.192

Review 2.  Interferons and their stimulated genes in the tumor microenvironment.

Authors:  Hyeonjoo Cheon; Ernest C Borden; George R Stark
Journal:  Semin Oncol       Date:  2014-02-14       Impact factor: 4.929

Review 3.  Interferon signaling in cancer. Non-canonical pathways and control of intracellular immune checkpoints.

Authors:  Diana Saleiro; Leonidas C Platanias
Journal:  Semin Immunol       Date:  2019-06       Impact factor: 11.130

4.  SLFN11 inhibits checkpoint maintenance and homologous recombination repair.

Authors:  Yanhua Mu; Jiangman Lou; Mrinal Srivastava; Bin Zhao; Xin-hua Feng; Ting Liu; Junjie Chen; Jun Huang
Journal:  EMBO Rep       Date:  2015-12-09       Impact factor: 8.807

5.  The correlation between the expression of differentiation markers in rat small intestinal mucosa and the transcript levels of schlafen 3.

Authors:  Pavlo L Kovalenko; Marc D Basson
Journal:  JAMA Surg       Date:  2013-11       Impact factor: 14.766

Review 6.  Regulation of interferon-dependent mRNA translation of target genes.

Authors:  Barbara Kroczynska; Swarna Mehrotra; Ahmet Dirim Arslan; Surinder Kaur; Leonidas C Platanias
Journal:  J Interferon Cytokine Res       Date:  2014-02-21       Impact factor: 2.607

7.  Schlafen 3 changes during rat intestinal maturation.

Authors:  Mary F Walsh; Rebecca Hermann; Kelian Sun; Marc D Basson
Journal:  Am J Surg       Date:  2012-08-17       Impact factor: 2.565

8.  Selection of reference genes for use in quantitative reverse transcription PCR assays when using interferons in U87MG.

Authors:  Dania Vázquez-Blomquist; Julio Raúl Fernández; Jamilet Miranda; Claudia Bello; José A Silva; Regla C Estrada; Lidia Inés Novoa; Daniel Palenzuela; Iraldo Bello
Journal:  Mol Biol Rep       Date:  2012-10-14       Impact factor: 2.316

9.  SCHLAFEN 5 expression correlates with intestinal metaplasia that progresses to gastric cancer.

Authors:  Osmel Companioni Nápoles; Amy C Tsao; José Miguel Sanz-Anquela; Núria Sala; Catalina Bonet; María Luisa Pardo; Lin Ding; Ornella Simo; Milena Saqui-Salces; Verónica Parra Blanco; Carlos A Gonzalez; Juanita L Merchant
Journal:  J Gastroenterol       Date:  2016-03-31       Impact factor: 7.527

10.  Schlafen 4-expressing myeloid-derived suppressor cells are induced during murine gastric metaplasia.

Authors:  Lin Ding; Michael M Hayes; Amanda Photenhauer; Kathryn A Eaton; Qian Li; Ramon Ocadiz-Ruiz; Juanita L Merchant
Journal:  J Clin Invest       Date:  2016-07-18       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.